Atypical Lobular Breast Hyperplasia
NCI Definition: Lobular neoplasia characterized by lobular epithelial proliferation that does not completely fill the lobular unit of the breast. 
There is 1 clinical trial for atypical lobular breast hyperplasia, of which 1 is open and 0 are completed or closed. Of the trial that contains atypical lobular breast hyperplasia as an inclusion criterion, 1 is phase 2 (1 open).
Placebo and ruxolitinib are the most common interventions in atypical lobular breast hyperplasia clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.